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Respiratory Syncytial Virus Infects Primary Neonatal 
and Adult Natural Killer Cells and Affects Their Antiviral 
Effector Function
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Background.  Respiratory syncytial virus (RSV) is a major cause of severe acute lower respiratory tract infections in infants. Natural 
killer (NK) cells are important antiviral effector cells that likely encounter RSV in the presence of virus-specific (maternal) antibodies. 
As NK cells potentially contribute to immunopathology, we investigated whether RSV affects their antiviral effector functions.
Methods. We assessed the phenotype and functionality of primary neonatal and adult NK cells by flow cytometry after stimula-
tion with RSV or RSV-antibody complexes.
Results. We demonstrate for the first time that RSV infects neonatal and adult NK cells in vitro. Preincubation of virus with 
subneutralizing concentrations of RSV-specific antibodies significantly increased the percentage of infected NK cells. Upon infec-
tion, NK cells were significantly more prone to produce interferon-γ, while secretion of the cytotoxicity molecule perforin was not 
enhanced.
Conclusions. Our findings suggest that (antibody-enhanced) RSV infection of NK cells induces a proinflammatory rather than a 
cytotoxic response, which may contribute to immunopathology. Considering that most RSV vaccines currently being developed aim 
at inducing (maternal) antibodies, these results highlight the importance of understanding the interactions between innate effector 
cells and virus-specific antibodies.
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Human respiratory syncytial virus (RSV) is a major cause of 
severe lower respiratory tract disease in infants [1]. There are 
currently no market-approved vaccines or antivirals avail-
able against this virus. The estimated global burden of RSV-
associated severe acute lower respiratory infection was 33.1 
million in 2015, with an estimated 118 200 deaths in children 
<5  years of age [2]. Hospitalization for severe RSV-mediated 
disease peaks between 6 weeks and 6 months of life [3], when 
infants mainly depend on maternal antibodies and their innate 
immune system for protection against infectious diseases. 
Despite extensive research efforts, the immunological determi-
nants of severe RSV-mediated disease remain elusive.
Natural killer (NK) cells are innate lymphocytes that play an 
important role in the control of viral lung infections. Within 
days after infection, large numbers of NK cells are recruited 
to the lung and become activated [4, 5]. NK cells have multi-
ple mechanisms to combat viral replication: (1) death recep-
tor–mediated cytolysis to kill virus-infected target cells, (2) 
production of proinflammatory cytokines with antiviral 
activity (eg, interferon gamma [IFN-γ]), and (3) antibody-de-
pendent cell-mediated cytotoxicity, in which NK cells bind anti-
body-coated virus-infected target cells via Fc gamma receptor 
III (FcγRIII)/CD16 followed by target cell lysis.
The role of NK cells during RSV-induced disease is still 
unclear. In mice, increased numbers of NK cells are present 
in the lungs early after RSV infection [4–6]. In this model, the 
presence of NK cells is sufficient to eliminate RSV infection [7] 
and depletion of NK cells significantly increases viral loads [8]. 
However, increasing evidence suggests that NK cells also con-
tribute to inflammatory lung injury, for example via the produc-
tion of IFN-γ [5, 8, 9].
 There are contradictory reports on NK cells in humans 
during severe RSV infection. In infants, the proportion of 
NK cells has been reported both to be decreased [10–13] or 
increased [14, 15] in comparison with healthy controls or 
infants with mild symptoms. NK cell gene expression in whole 
blood was reported to be downregulated in infants with severe 
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RSV disease compared with controls [16]. Therefore, definitive 
conclusions about the role of NK cells in RSV infection and dis-
ease cannot be drawn from the data currently available.
In this study, we investigated whether interaction of RSV 
or RSV-antibody complexes with NK cells affects their func-
tion. Interestingly, we found that RSV infects NK cells and 
that infection influenced the effector function of both neona-
tal and adult NK cells. RSV-infected NK cells were more prone 
to produce IFN-γ than uninfected cells, while the percentage 
of perforin-secreting cells was not increased. We show that 
preincubation of RSV with subneutralizing concentrations 
of virus-specific antibodies increases the number of infected 
and, hence, IFN-γ–secreting NK cells. We propose that (anti-
body-enhanced) infection of NK cells with RSV may contribute 
to immunopathology, through induction of a proinflammatory 
rather than a cytotoxic response in these cells.
MATERIALS AND METHODS
Cells and Viruses
Peripheral blood mononuclear cells (PBMCs) were obtained 
from healthy volunteers at the National Institute for Public 
Health and the Environment (RIVM, the Netherlands). Cord 
blood mononuclear cells (CBMCs) from umbilical cords of 
healthy neonates born by cesarean delivery were collected at 
Radboudumc Nijmegen (the Netherlands). Blood was collected 
in heparin tubes and the mononuclear fraction was isolated by 
density gradient centrifugation (Lymphoprep, Nycomed). NK 
cells were purified by negative selection using a CD56+ NK cell 
isolation kit (Miltenyi Biotec). In all experiments, NK cells were 
gated as the CD3(–), CD56(+) population. Isolated cells were cul-
tured in Iscove’s Modified Dulbecco’s Media (IMDM; Gibco) sup-
plemented with 10% heat-inactivated fetal calf serum (hiFCS), 
1% penicillin/streptomycin/glutamine (PSG, Gibco), and 5  ng/
mL recombinant interleukin 15 (IL-15; Biolegend). CBMCs were 
stored at –135°C and thawed before NK cell isolation.
Vero cells (ATCC-CCL81) were propagated in Dulbecco’s 
modified Eagle’s medium supplemented with 5% hiFCS and 1% 
PSG. Human chronic myelogenous leukemic K562 cells (a kind 
gift from Jeannette Cany, Radboudumc Nijmegen) were prop-
agated in IMDM, supplemented with 10% hiFCS and 1% PSG.
Recombinant RSV-X and RSV-X-GFP7 (encoding green 
fluorescent protein [GFP]) were propagated in Vero cells as 
described before [17, 18]. Virus stocks were purified between 
layers of 10% and 50% sucrose by ultracentrifugation. The 50% 
tissue culture infectious dose (TCID50)/mL was determined on 
Vero cells using the Spearman and Karber method [19].
Plaque Reduction Neutralization Test
Using RSV-X-GFP7, a Vero-based plaque reduction neutraliza-
tion test was performed for intravenous immunoglobulin (IVIg; 
KIOVIG, Baxalta), palivizumab (SYNAGIS, AbbVie), and the 
World Health Organization (WHO) International Standard for 
antiserum to RSV (National Institute for Biological Standards 
and Control [NIBSC]), as described previously [18]. Based on 
the neutralization curves, the amount of international units 
(IU) of anti-RSV neutralizing antibodies per milliliter was cal-
culated for IVIg and palivizumab using the WHO standard as 
reference serum (containing 2000 IU/mL).
RSV Infection
NK cells were infected with RSV-X-GFP7 or RSV-X by spinoc-
ulation for 1 hour at 700g at 20°C, followed by incubation for 1 
hour at 37°C. A  multiplicity of infection (MOI) of 1 based on 
titration on Vero cells was used. Next, cells were washed with 
phosphate-buffered saline and replenished with culture medium. 
For antibody-dependent enhancement (ADE) assays, RSV was 
preincubated with the indicated concentrations of IVIg or paliv-
izumab for 10 minutes at 37°C, before spinoculation of NK cells. 
Incubation at 37°C was followed by flow cytometric analysis at the 
indicated time points using an LSR Fortessa X20 (BD Biosciences). 
RSV infection was blocked by coincubation with 100 nM fusion 
inhibitor (TMC-353121, MCE) [20]. FcγRIII/CD16 was blocked 
by preincubation of NK cells with 50 µg/mL anti-CD16 Fab frag-
ments (3G8, Ancell). Infection was measured by GFP expression 
for RSV-X-GFP7 or with a fluorescein isothiocyanate (FITC)–
conjugated RSV-G antibody (131-2G, Millipore). Productivity of 
NK cell infection was assessed by TCID50 of the cleared superna-
tants on Vero cells as described above.
Flow Cytometric Phenotypic Characterization
The following fluorochrome-conjugated monoclonal anti-
bodies were used to phenotypically characterize (RSV-
infected) NK cells: CD3-APCAF750 (UCHT1, Beckman 
Coulter), CD16-PacificOrange (3G8, Thermo Fisher), CD56-
ECD (N901, Beckman Coulter), CD85j-PerCP-Cy5.5 (ILT2, 
LILRB1; GHI/75, BioLegend), CD161-APC (191B8, Miltenyi), 
CD158a-AF700 (KIR2DL1; 143211, R&D Systems), CD158a/
h-PC5.5 (KIR2DL1/S1; EB6B, Beckman Coulter), CD158b1/
b2,j-PC7 (KIR2DL2/L3/S2; GL183, Beckman Coulter), 
CD158e1-BV421 (KIR3DL1; DX9, BioLegend), CD159a-APC 
(NKG2A; Z199, Beckman Coulter), CD159c-PE (NKG2C; 
134591, R&D Systems), CD244-AF700 (2B4; C1.7, BioLegend), 
CD314-APC (NKG2D; ON72, Beckman Coulter), CD335-PC7 
(NKp46; BAB281, Beckman Coulter), CD336-PE (NKp44; 
Z231, Beckman Coulter), CD337-PerCP-Cy5.5 (NKp30; P30-
15, BioLegend), RSV-G-FITC (131-2G, Millipore). Cells were 
measured using a Navios flow cytometer (Beckman Coulter).
NK Activation Assay
At 20 hours postinfection with RSV or RSV-antibody com-
plexes, the NK cells were incubated for 4 hours in the absence 
or presence of K562 target cells together with brefeldin A (BD 
Bioscience) and CD107a-PE/Cy7 antibody (H4A3, Biolegend). 
Subsequently, cells were stained using the following antibod-
ies: CD56-PE (HCD56, Biolegend), CD3-PerCP (SK7, BD 
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Biosciences), RSV-G-FITC (131-2G, Millipore), IFN-γ–APC 
antibody (B27, BD Bioscience), perforin-BV421 (B-D48, 
Biolegend), and fixable viability dye eFluor780 (eBioscience).
Statistical Analysis
Comparison of 2 groups or data points was performed by using 
a nonparametric Wilcoxon signed-rank test. Multiple compar-
isons were analyzed by using a nonparametric Friedman test, 
followed by Dunn multiple comparisons test. P values <.05 were 
considered statistically significant. All statistical analyses were 
performed with Prism 7 software (GraphPad).
Ethics Statement
All blood donors (PBMCs) and mothers (CBMCs) provided 
written informed consent.
RESULTS
RSV Infects and Replicates in Primary Adult NK Cells
To assess the interaction of RSV with NK cells, primary adult 
NK cells (>95% CD3[–] cells) were spinoculated with RSV-
X-GFP7 at a Vero-based MOI of 1.  We observed steadily 
increasing expression of virus-encoded GFP, which is indicative 
of viral replication. In a time-course experiment, the maximum 
percentage of GFP-positive NK cells (CD3[–], CD56[+]) was 
observed at 24 hours postinfection (Figure 1A). The level of RSV 
infection showed considerable donor variability, and reached a 
maximum of up to 20% infected NK cells in some donors. The 
amount of intracellular GFP increased over time as shown by 
the Median Fluorescence Intensity (MFI) (Figure 1B). TCID50 
assays of the NK cell supernatant showed a decrease in viral titer 
over time, suggesting that little or no infectious viral particles 
were released (Figure 1C). Inoculation of NK cells with RSV-X-
GFP7 in the presence of a fusion inhibitor (TMC) showed effi-
cient inhibition of NK cell infection (Figure 1D), indicating that 
viral entry was required for GFP detection and depended on the 
fusion (F) protein. The TMC vehicle control (dimethyl sulfox-
ide) showed no effect on infection (Supplementary Figure 1A). 
Moreover, increasing the titer of the inoculum resulted in con-
siderably higher infection rates (Supplementary Figure  1B), 
suggesting that RSV does not exclusively infect a minor NK cell 
subpopulation. Altogether, these data show that RSV infects 
primary adult NK cells in vitro.
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Figure 1. Respiratory syncytial virus (RSV) infects primary natural killer (NK) cells in vitro. A and B, Flow cytometric analysis showing the percentage (A) or median fluo-
rescence intensity (B) of green fluorescent protein–positive cells for adult primary NK cells after spinoculation with RSV-X-GFP7 (multiplicity of infection = 1). Graphs depict 
geometric mean and standard deviation (SD) of 4 donors pooled from 2 independent experiments. C, The 50% tissue culture infectious dose of cleared RSV-infected NK cell 
supernatant on Vero cells. Graph depicts geometric mean and SD of 3 donors from 1 experiment. The dashed line depicts the retitration of the initial RSV inoculum. D, NK 
cells were spinoculated with RSV-X-GFP7 in the absence or presence of a fusion inhibitor (TMC) and infection was measured by flow cytometry at 20 hours postinfection. 
Data were pooled from 6 independent experiments and each set of paired data points represents an individual donor (n = 14). Wilcoxon signed-rank test was used for com-
parison between conditions (***P < .001). Abbreviations: GFP, green fluorescent protein; h.p.i., hours postinfection; MFI, median fluorescence intensity; NK, natural killer; RSV, 
respiratory syncytial virus; TCID50, 50% tissue culture infectious dose.
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Nonneutralizing RSV-Specific Antibodies Enhance NK Cell Infection
The vast majority of individuals infected with RSV possess RSV-
specific antibodies, which vary in concentration and are either 
maternally derived through transplacental transfer or induced 
by previous exposure. NK cells that are recruited to the lung 
most likely encounter viral particles in complex with these anti-
bodies. Since immunoglobulin G levels in the lung are lower 
than those found in serum [21], even neutralizing concentra-
tions of serum antibodies may be accompanied by nonneu-
tralizing antibody levels in the lung. Here we show that, while 
high antibody concentrations result in virus neutralization, 
incubation of NK cells with RSV-antibody complexes formed 
at subneutralizing concentrations results in ADE of infection 
(Figure 2A). This was shown for both IVIg, naturally contain-
ing RSV-specific antibodies, and palivizumab, a RSV-specific 
monoclonal antibody targeting the F protein. IVIg showed 
maximum enhancement around 1  μg/mL, corresponding to 
0.0027 IU/mL of anti-RSV neutralizing antibodies. For palivi-
zumab, maximum enhancement was observed at 0.03 μg/mL, 
corresponding to 0.0013 IU/mL. The standardized neutralizing 
antibody concentrations of IVIg and palivizumab were calcu-
lated using the WHO International Standard for antiserum to 
RSV as a reference (Supplementary Figure 1C).
Incubation of NK cells with RSV-antibody complexes formed 
at subneutralizing antibody concentrations (5 µg/mL or 0.014 
IU/mL IVIg), resulted in up to 4-fold increased infection com-
pared to the absence of antibodies (Figure 2B). Neutralizing anti-
body concentrations (500 µg/mL or 1.4 IU/mL IVIg) completely 
inhibited infection. ADE of infection was completely blocked in 
the presence of TMC, indicating that viral entry still depended 
on the F protein (Figure 2C). ADE of NK cell infection seems to 
involve CD16/FcγRIII, as incubation with CD16-blocking Fab 
fragments decreased infection in the presence but not in the 
absence of RSV-specific antibodies, although this difference was 
not statistically significant (Figure 2D). Spinoculation was used 
to enhance infection in all experiments, but this had no effect 
on the fold increase of antibody-enhanced infection compared 
to regular infection (Supplementary Figure 1D).
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Figure 2. Antibody-dependent enhancement of respiratory syncytial virus (RSV) infection in natural killer (NK) cells. A, Infection of adult primary NK cells in the presence 
of RSV-X-GFP7-antibody complexes (with the indicated concentration of intravenous immunoglobulin [IVIg] or palivizumab). Graph depicts the geometric mean and standard 
deviation (SD) of 3 donors from 1 experiment. Dashed line depicts the geometric mean percentage green fluorescent protein (GFP)–positive cells in absence of antibodies (no 
antibodies). B, Infection of NK cells with RSV-X-GFP7 or (sub)neutralizing RSV-antibody complexes (5 µg/mL or 500 µg/mL IVIg). Data were pooled from 6 independent exper-
iments and each set of paired data points represents an individual donor (n = 14). C, Infection of NK cells with subneutralizing RSV-antibody complexes (5 µg/mL IVIg) in the 
absence or presence of a fusion inhibitor (TMC). Data were pooled from 6 independent experiments and each set of paired data points represents an individual donor (n = 14). 
D, Infection of NK cells in the absence or presence of subneutralizing RSV-antibody complexes (5 µg/mL IVIg) with 50 µg/mL CD16-blocking Fab fragments. Graph depicts the 
geometric mean and SD of 3 donors from 1 experiment. All GFP measurements were performed by flow cytometry at 20 hours postinfection. Nonparametric Friedman test 
with Dunn multiple comparisons test was used for comparisons between multiple conditions (*P < .05, ****P < .0001). Wilcoxon signed-rank test was used for comparison 
between 2 conditions (***P < .001). Abbreviations: Abs, antibodies; ADE, antibody-dependent enhancement; GFP, green fluorescent protein; h.p.i., hours postinfection; IVIg, 
intravenous immunoglobulin; NK, natural killer; RSV, respiratory syncytial virus.
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Phenotypic Characterization of RSV-Infected NK Cells
Next, we set out to determine the phenotypic characteristics 
of RSV-infected NK cells using an extensive NK cell receptor 
panel. Those receptors showing the most pronounced effect 
upon infection are shown in Figure 3; the remaining receptors 
are depicted in Supplementary Figure 2. In the presence of sub-
neutralizing RSV-antibody complexes, the activation markers 
NKG2D and NKp44 are downregulated (Figure 3A and 3B). The 
presence of RSV alone has a similar, but nonsignificant effect. In 
contrast, the HLA-C–specific killer cell immunoglobulin-like 
receptors KIR3DL1, which is inhibitory, and KIR2DL2/L3/S2, 
which can be activating or inhibiting, were more abundantly 
expressed on RSV-infected NK cells compared to mock-in-
fected cells (Figure 3C and 3D). Taken together, although the 
effect on individual markers is not very dramatic, RSV-infected 
NK cells appear to be skewed toward an inhibitory phenotype.
Neonatal NK Cells Are Susceptible to (Antibody-Enhanced) RSV Infection
RSV is known to cause the most severe symptoms in the first 
months of life [3]. Therefore, the cells that are present at the 
moment of severe RSV disease in infants may more closely 
resemble umbilical cord blood NK cells than adult cells. 
We found that also neonatal NK cells (>90% CD3[–] cells) 
could be infected by RSV in vitro, and that infection was 
blocked by the fusion inhibitor TMC (Figure 4A). Neonatal 
NK cells showed a 6-fold increase in infection upon incu-
bation with RSV-antibody complexes formed at subneutral-
izing antibody concentrations (5  µg/mL IVIg) compared 
to the no-antibody control (Figure  4B). Neutralizing anti-
body concentrations (500 µg/mL IVIg) completely inhibited 
infection. Overall, these results show that neonatal NK cells 
are comparable to adult NK cells in their susceptibility to 
RSV infection.
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Figure 3. Phenotypic characterization of respiratory syncytial virus (RSV)–infected natural killer (NK) cells. A–C, Adult primary NK cells were inoculated with RSV-X or 
subneutralizing RSV-X antibody complexes (5 µg/mL intravenous immunoglobulin) and stained with 3 different antibody panels for flow cytometric analysis at 20 hours 
postinfection. RSV-infected and uninfected populations within 1 well are indicated with (+) and (-), respectively. Geometric mean of fluorescence intensity is depicted for the 
markers with the most pronounced differences compared to mock-infected NK cells: activating receptors NKG2D (A) and NKp44 (B), and KIRs KIR3DL1 (C), which is inhibi-
tory, and KIR2DL2/L3/S2 (D), which can be either activating or inhibiting. Graphs depict the geometric mean and standard deviation of 6 donors pooled from 2 independent 
experiments. Nonparametric Friedman test with Dunn multiple comparisons test was used for comparison between multiple conditions (*P < .05, **P < .01, ***P < .001). 
Abbreviations: gMFI, geometric mean fluorescence intensity; IVIg, intravenous immunoglobulin; KIR, killer cell immunoglobulin-like receptor; NK, natural killer; RSV, respira-
tory syncytial virus.
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RSV Infection of NK Cells Induces IFN-γ Production
Because RSV infection of immune cells can have a profound 
effect on their functionality [22–24], we set out to explore 
the effect of RSV infection on NK cell functionality. First, we 
assessed IFN-γ production in 4 different NK cell populations: 
(1) mock-infected control cells; RSV-exposed (2) infected and 
(3) uninfected cells; and (4) uninfected cells exposed to RSV 
in the presence of TMC. The gating strategy for the NK cell 
activation assays is depicted in Supplementary Figure 3. RSV-
infected neonatal NK cells showed significantly more IFN-γ–
expressing cells compared to all control conditions (Figure 5A). 
CD107a, a marker of NK cell activity, was also upregulated in 
RSV-infected NK cells (Supplementary Figure 4). In agreement 
with the results obtained for infection by RSV in the absence 
of antibodies, infection of neonatal NK cells by RSV-antibody 
complexes resulted in even more IFN-γ–expressing cells 
(Figure 5B). Similar results were obtained using adult NK cells 
(Figure 5C and 5D). In summary, both neonatal and adult NK 
cells are prone to produce IFN-γ upon RSV infection, and ADE 
of infection increases the total number of IFN-γ–positive cells 
by increasing the number of infected cells.
RSV Infection of NK Cells Does Not Enhance Perforin Secretion
In addition to IFN-γ secretion, an important NK cell function 
is the secretion of granzymes and perforins to induce target cell 
death. Upon encountering a cytotoxicity trigger, for example, 
virus-infected or tumor cells, NK cells rapidly release preexisting 
granules containing both granzymes and perforins. Secretion of 
these granules results in a loss of intracellular perforin staining, 
which can be detected by flow cytometry [25]. This experimen-
tal approach allows for the discrimination between infected and 
uninfected cell responses in the same well, which would not 
be possible by measuring perforin released in the supernatant. 
We determined the percentage of perforin-negative cells as a 
measure for perforin secretion in 5 different NK cell popula-
tions: (1) mock-infected control cells without K562 target cells; 
(2) mock-infected control cells with target cells; RSV-exposed 
(3) infected and (4) uninfected cells with target cells; and (5) 
uninfected cells exposed to RSV in the presence of TMC with 
target cells.
Perforin secretion was slightly increased in all condi-
tions upon the addition of target cells to neonatal NK cells 
(Figure 6A). Although RSV-infected NK cells are considerably 
more prone to produce IFN-γ than control cells (Figure  5A), 
this was not the case for perforin secretion. When neonatal 
NK cells were incubated with subneutralizing antibody con-
centrations (5  µg/mL IVIg), only the RSV-negative cells were 
significantly more likely to secrete perforin than unstimulated 
cells, possibly due to activation by neighboring opsonized RSV-
infected NK cells (Figure 6B).
Since neonatal NK cells are described to be intrinsically less 
cytotoxic than adult NK cells [26, 27], we investigated whether 
the latter were more reactive in our cytotoxicity assay. Unlike 
neonatal cells, adult NK cells showed a significant increase in 
perforin secretion upon addition of target cells, supporting 
the reportedly low cytotoxic capability of neonatal NK cells 
(Figure  6C). Strikingly, only RSV-infected NK cells did not 
show significantly increased perforin secretion upon addi-
tion of target cells. ADE of NK cell infection enhanced this 
effect, resulting in a significant difference in perforin secretion 
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Figure 4. Neonatal natural killer (NK) cells are susceptible to respiratory syncy-
tial virus (RSV) infection. Human neonatal NK cells were spinoculated with RSV-
X-GFP7 (multiplicity of infection  =  1). A, Percentage infected cells in absence or 
presence of a fusion inhibitor (TMC) as measured by flow cytometry. Data were 
pooled from 2 independent experiments and each set of paired data points rep-
resents an individual donor (n = 8). B, Percentage of infected cells after inoculation 
with RSV or RSV-antibody complexes (5 µg/mL or 500 µg/mL intravenous immuno-
globulin). Data were pooled from 2 independent experiments and each set of paired 
data points represents an individual donor (n = 6). Wilcoxon signed-rank test was 
used for comparison between 2 conditions (***P < .001). Nonparametric Friedman 
test with Dunn multiple comparisons test was used for comparison between multi-
ple conditions (**P < .01). Abbreviations: ADE, antibody-dependent enhancement; 
GFP, green fluorescent protein; IVIg, intravenous immunoglobulin; NK, natural killer; 
RSV, respiratory syncytial virus.
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between infected and uninfected NK cells in the same well 
(Figure 6D). These data suggest that, unlike what was seen for 
IFN-γ, the secretion of perforin is not enhanced and is possibly 
even reduced in RSV-infected adult NK cells.
DISCUSSION
In the past, it was thought that epithelial cells were the only tar-
get of RSV [11, 28]. However, there is increasing evidence that 
RSV is also able to infect immune cells in humans [22, 23], and 
viral RNA has been detected in peripheral blood cells during 
acute infection [29]. In our experiments, infected NK cells did 
not release infectious viral particles, which is consistent with 
studies of RSV infection in other immune cells [24, 30, 31]. 
Infection of NK cells has been documented before for several 
unrelated viruses (including human immunodeficiency virus, 
vaccinia virus, human herpesvirus 6, and influenza virus), and 
only some of these establish productive infections [32–35].
Considering that NK cells, recruited to the lungs during 
infection in infants, likely encounter RSV bound to (subneu-
tralizing levels of) virus-specific antibodies, it is probable that 
Fc gamma receptor (FcγR)–mediated antibody effector func-
tions are activated. Recently, researchers found that antibodies 
with enhanced binding to CD16/FcγRIII determined disease 
severity in dengue infection [36]. Moreover, in vitro ADE of 
RSV infection has been shown before by several groups includ-
ing our own [37–39]. In the current study, we show that in the 
presence of subneutralizing antibody concentrations, infection 
of NK cells can be enhanced up to 4-fold for adult NK cells and 
up to 6-fold for neonatal NK cells, resulting in a substantial pro-
portion of infected NK cells in vitro. Further research is needed 
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to determine the exact contribution of CD16/FcγRIII to ADE of 
RSV infection in NK cells.
We show that RSV infection of NK cells results in increased 
numbers of IFN-γ–producing cells. In mouse models of RSV 
infection, NK cells were shown to be the most important source 
of IFN-γ early after infection [4, 5]. However, the role of IFN-γ 
in RSV disease has been much debated. On the one hand, it has 
been suggested that IFN-γ is involved in acute lung injury, aller-
gic airway disease, and airway obstruction in animal models [5, 
40, 41] and appears to be associated with virus-induced wheez-
ing in humans [42]. On the other hand, decreased IFN-γ levels 
were found in the blood and in the nasopharyngeal aspirates 
of mechanically ventilated infants compared to nonventilated 
infants [43, 44]. However, it is debatable whether measurements 
in the blood accurately reflect IFN-γ levels in the lungs during 
RSV infection. Also, in a more recent study, IFN-γ levels were 
found to be elevated during RSV bronchiolitis when measured 
by nasosorption, but not in nasopharyngeal aspirates, showing 
a clear effect of sampling technique [45]. Considering these 
findings, it seems that the detrimental effects of IFN-γ are an 
exacerbated outcome of an intrinsically beneficial role for this 
molecule in protection against RSV disease. We have shown 
that RSV infection of NK cells leads to more IFN-γ–produc-
ing cells, a potential way through which the virus disturbs the 
balanced NK cell response. In contrast to the increase in IFN-γ 
production in RSV-infected NK cells, we did not observe more 
perforin secretion upon RSV infection. Adult NK cells infected 
in the presence of RSV-antibody complexes even showed sig-
nificantly lower perforin secretion than uninfected cells in the 
same well. This effect is likely only seen in adult NK cells because 
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of the intrinsically lower capacity of neonatal NK cells to elicit a 
cytotoxic response. This is also evidenced by the almost 10-fold 
lower MFI for perforin in neonatal compared to adult NK cells 
(data not shown). Overall, we only observed minor differences 
between neonatal and adult NK cells. This was an unexpected 
finding, as earlier studies show more RSV infection in neonatal 
compared to adult monocytes [46] and severely decreased cyto-
toxic responses by neonatal NK cells [26, 27]. Our experiments 
were performed with the addition of small amounts (5  ng/
mL) of IL-15. This has been shown to increase the functional-
ity of neonatal NK cells [27] and possibly explains the limited 
differences between adult and neonatal NK cells in our study. 
Moreover, high variability has been observed between cord 
blood donors in earlier studies [47] with some donors exhibit-
ing similar or even higher cytotoxicity levels than adult donors.
Of note, in our experiments, CD107a expression correlated 
with IFN-γ production but not with perforin secretion. This 
suggests that CD107a is not merely a secretion marker of perfo-
rin, but acts as a more general marker for NK cell activity.
Increased IFN-γ production together with a possible inhibi-
tion of perforin secretion suggests a shift toward a proinflam-
matory rather than a cytotoxic NK cell state. In addition, the 
phenotypic characteristics of RSV-infected NK cells suggest 
skewing toward a less cytotoxic and more inhibitory phenotype. 
This may impair the cytolytic function of these cells, as has been 
shown for other viruses [35, 48]. Based on previous reports and 
the data described in this article, we propose that the proinflam-
matory response of RSV-infected NK cells may contribute to 
the development of RSV-mediated severe disease. Notably, the 
formalin-inactivated RSV vaccine that caused enhanced dis-
ease upon natural infection induced primarily nonneutralizing 
antibodies [49]. Our data support the idea that these antibodies 
may have contributed to enhanced inflammation [50].
To conclude, we have shown that RSV-infected NK cells are more 
prone to produce IFN-γ than uninfected cells, whereas the cytotoxic 
response is not increased. This combination may contribute to RSV 
immunopathology in vivo, but more research is needed to support 
this hypothesis. Moreover, we show that Fc-mediated effector func-
tions such as ADE of infection can have a profound effect on the 
immune response and a potential role in the development of dis-
ease. Our findings contribute to the understanding of the potential 
mechanisms responsible for the development of severe RSV disease 
and highlight the critical need to further characterize the role of NK 
cells and RSV-antibody complexes therein, as this will assist in the 
development of safe and effective RSV vaccines.
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